HUTCHMED (China) Limited (AIM:HCM)
London · Delayed Price · Currency is GBP · Price in GBX 224.50
-21.00 (-8.55%)
Aug 8, 2025, 4:35 PM GMT+1
Satixfy Communications Market Cap
HUTCHMED (China) has a market cap or net worth of 1.93 billion as of August 8, 2025. Its market cap has decreased by -20.72% in one year.
Market Cap
1.93B
Enterprise Value
1.02B
Revenue
439.54M
Ranking
n/a
PE Ratio
5.81
Stock Price
$224.50
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 128.29M to 1.93B, an increase of 1,403.77%. That is a compound annual growth rate of 15.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 1.93B | -3.95% |
| Dec 31, 2024 | 2.01B | -16.84% |
| Dec 29, 2023 | 2.42B | 8.25% |
| Dec 30, 2022 | 2.23B | -50.85% |
| Dec 31, 2021 | 4.54B | 36.26% |
| Dec 31, 2020 | 3.33B | 31.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.37B |
| GSK plc | 56.29B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| Genus | 1.66B |